Table 1. Demographic and treatment characteristics for intervention and control group.
| Characteristic | Intervention (n = 25) | Control (n = 25) | |||
|---|---|---|---|---|---|
| Age (years) M (SD) | 52.08 (11.7) | 52.36 (8.9) | p = .500 | ||
| BMI M (SD) | 27.20 (4.82) | 28.25 (5.83) | p = .501 | ||
| N | % | N | % | x2 | |
| Education | |||||
| None | 3 | 12 | 6 | 24 | |
| GCSE (or equivalent) | 11 | 44 | 9 | 36 | |
| A level (or equivalent) | 3 | 12 | 7 | 28 | .279 |
| Degree | 5 | 20 | 2 | 8 | |
| Higher Degree | 3 | 12 | 1 | 4 | |
| Marital status | |||||
| Single | 2 | 8 | 3 | 12 | |
| Married/living with partner | 19 | 76 | 19 | 76 | |
| Separated/divorced | 3 | 12 | 2 | 8 | |
| Widowed | 1 | 4 | 1 | 4 | .940 |
| Employment status | |||||
| Working | 5 | 20 | 5 | 20 | |
| Sick leave | 17 | 68 | 16 | 64 | |
| Retired | 3 | 12 | 4 | 16 | .917 |
| Breast cancer type | |||||
| Invasive ductal | 24 | 96 | 23 | 92 | |
| Invasive lobular | 1 | 4 | 2 | 8 | .552 |
| Cancer grade | |||||
| I | 0 | 0 | 1 | 4 | |
| II | 5 | 20 | 8 | 32 | |
| III | 20 | 80 | 16 | 64 | .344 |
| Chemotherapy type | |||||
| FEC | 12 | 48 | 9 | 36 | |
| FEC-T | 13 | 52 | 16 | 64 | .390 |
| Treatment type | |||||
| Adjuvant | 20 | 80 | 21 | 84 | |
| Neo-adjuvant | 5 | 20 | 4 | 16 | .713 |
| Surgery type | |||||
| Lumpectomy | 17 | 68 | 15 | 60 | |
| Mastectomy | 7 | 28 | 10 | 40 | |
| Segmental | 1 | 4 | 0 | 0 | .437 |
| Menopausal status | |||||
| Pre-menopausal | 12 | 48 | 7 | 28 | |
| Post-menopausal | 13 | 52 | 18 | 72 | .150 |
| Self-report physical activity | |||||
| Inactive | 16 | 64 | 15 | 60 | |
| Moderately inactive | 4 | 16 | 4 | 16 | |
| Moderately active | 5 | 20 | 6 | 24 | |
| Active | 0 | 0 | 0 | 0 | .940 |
Note. FEC (fluorouracil, epirubicin and cyclophosphamide); FET-T (FEC followed by taxotere).